Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Syncona Limited NPV (SYNC)

Sector:

Investment Firms

Index:

FTSE 250

120.20p

Change Today:

-1.80p
52 Week High: 162.20
52 Week Low: 106.20

Currency: UK Pounds
Shares Issued: 652.48m
Volume: 229,344

Market Cap: £784.28m
RiskGrade: 291
Beta: 0.03

News Channel

Syncona shares slump as Novartis ends eye treatment development

By Frank Prenesti

Date: Monday 11 Sep 2023

LONDON (ShareCast) - (Sharecast News) - Syncona shares fell as the UK healthcare investment firm said Novartis had stopped the development of experimental eye treatment, GT005, resulting in milestone payments write-off of £54.5m for Gyroscope Holdings in which Syncona once held a 54% stake.
Gyroscope was sold to Novartis in February last year in $1.5bn deal, with Syncona receiving $442m (£326m) for its stake.

Email this article to a friend

or share it with one of these popular networks:

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

SYNC Market Data

Currency	UK Pounds
Share Price	120.20p
Change Today	-1.80p
% Change	-1.48 %
52 Week High	162.20
52 Week Low	106.20
Volume	229,344
Shares Issued	652.48m
Market Cap	£784.28m
Beta	0.03
RiskGrade	291